يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Staubach, Petra"', وقت الاستعلام: 1.61s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.

    المؤلفون: Staubach, Petra1 (AUTHOR), Alvaro‐Lozano, Montserrat2 (AUTHOR), Sekerel, Bulent Enis3 (AUTHOR), Maurer, Marcus4,5 (AUTHOR), Ben‐Shoshan, Moshe6 (AUTHOR), Porter, Miriam7 (AUTHOR), Hua, Eva8 (AUTHOR), Ji, Yan9 (AUTHOR), Burciu, Alis7 (AUTHOR), Savelieva, Marina7 (AUTHOR), Severin, Thomas7 (AUTHOR), Drollmann, Anton7 (AUTHOR) anton.drollmann@novartis.com, Bienczak, Andrzej7 (AUTHOR)

    المصدر: Pediatric Allergy & Immunology. Jul2023, Vol. 34 Issue 7, p1-11. 11p.

    مصطلحات موضوعية: *TEENAGERS, *URTICARIA, *CLINICAL trials, *DRUG development, *MONOCLONAL antibodies


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis.

    المؤلفون: Novak, Natalija, Worm, Margitta, Staubach, Petra, Jutel, Marek, Sager, Angelika, Pfaar, Oliver

    المصدر: Clinical & Translational Allergy; Oct2022, Vol. 12 Issue 10, p1-12, 12p

    مصطلحات موضوعية: ALLERGIC rhinitis, POLLEN, ALLERGENS, CLINICAL trials, BIRCH

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    High Prevalence of Mental Disorders and Emotional Distress in Patients with Chronic Spontaneous Urticaria.

    المؤلفون: Staubach, Petra1, Dechene, Markus2, Metz, Martin3, Mager, Markus1, Siebenhaar, Frank1, Weller, Karsten3, Zezula, Peter4, Eckhardt-Henn, Annegret5, Maurer, Marcus3 marcus.maurer@charite.de

    المصدر: Acta Dermato-Venereologica. 2011, Vol. 91 Issue 5, p557-561. 5p. 1 Chart, 3 Graphs.

    مصطلحات موضوعية: *MENTAL illness, *LIABILITY for emotional distress, *URTICARIA, *ANXIETY disorders, *SOMATOFORM disorders, *PSYCHOMETRICS, *CLINICAL trials

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

    المؤلفون: Craig, Timothy J1 (AUTHOR) tcraig@pennstatehealth.psu.edu, Reshef, Avner2 (AUTHOR), Li, H Henry3 (AUTHOR), Jacobs, Joshua S4 (AUTHOR), Bernstein, Jonathan A5 (AUTHOR), Farkas, Henriette6 (AUTHOR), Yang, William H7 (AUTHOR), Stroes, Erik S G8 (AUTHOR), Ohsawa, Isao9 (AUTHOR), Tachdjian, Raffi10 (AUTHOR), Manning, Michael E11 (AUTHOR), Lumry, William R12 (AUTHOR), Saguer, Inmaculada Martinez13 (AUTHOR), Aygören-Pürsün, Emel14 (AUTHOR), Ritchie, Bruce15 (AUTHOR), Sussman, Gordon L16 (AUTHOR), Anderson, John17 (AUTHOR), Kawahata, Kimito18 (AUTHOR), Suzuki, Yusuke19 (AUTHOR), Staubach, Petra20 (AUTHOR)

    المصدر: Lancet. Apr2023, Vol. 401 Issue 10382, p1079-1090. 12p.

    مصطلحات موضوعية: *CLINICAL trials, *ANGIONEUROTIC edema, *RANIBIZUMAB, *PACIFIC Islanders, *GENETIC disorders, *MONOCLONAL antibodies


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث